주식/증권
➡️ 중립
관련 뉴스
Latigo Biotherapeutics, Inc. GAAP EPS of -$0.55 beats by $0.12
11/05/2026
Middleby outlines 2026 guidance raise to $7.13-$7.29 EPS as CEO transition set for April 1, 2027
11/05/2026
Ralph Lauren outlines fiscal 2027 revenue growth of 6% to 7% with 80 to 100 bps operating margin expansion
11/05/2026
Korro Bio GAAP EPS of -$0.98 beats by $0.38
11/05/2026